|
|
Kalbe Farma
ISE •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/05/2026 16:08
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeISE
Market Capitalization39,625,712 mln
Float18,046 mln
Earnings Date07/29/2025
1-Year Forecast
1,554
Transformational upside
Relative Strength
18
/ 100
Significantly lagging
Key Fundamentals
EPS80.50
P/E10.56
ROE15.94
RPS776
ROIC16.12
ROA12.19
Interest Cover129
EBITDA, mln5,179,678
EV / EBITDA8.08
EV / EBIT8.70
Revenue, mln35,324,544
EV / Revenue1.18
Financial Strength
Altman Z-Score7.69
Piotroski F-Score
6
/ 9
Beneish M-Score-2.37
Price to Intrinsic Value0.91
Price to Graham Number0.95
1-Year Target Price1,554
Shiller PE Ratio12.24
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-2.86% |
29
/ 100
 |
| 1 Month |
-12.37% |
4
/ 100
 |
| 2 Months |
-29.46% |
21
/ 100
 |
| 6 Months |
-30.33% |
12
/ 100
 |
| 1 Year |
-26.26% |
6
/ 100
 |
|
| |
